DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 


## **The Jane Hodge Foundation** 

**Registered number 216053** 

Trustees’ Report and Financial Statements 

30 September 2022 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Contents** 

|Trustees’ Report|1|
|---|---|
|Statement of Trustees’ Responsibilities in Respect of the Trustees’ Annual Report||
|and the Financial Statements|9|
|Independent Auditor’s Report to the Trustees of The Jane Hodge Foundation|10|
|Statement of Financial Activities|13|
|Balance Sheet|14|
|Statement of Cash Flows|15|
|Notes|16|





DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Trustees’ Report** 

The Trustees present their annual report together with the audited financial statements of the Charity for the year ended 30 September 2022.  The financial statements have been prepared in accordance with the accounting policies set out in note 1 and comply with the Foundation’s trust deed, the Charities Act 2011 and Accounting and Reporting by Charities (second edition October 2019): Statement of Recommended Practice applicable to charities in accordance with the Financial Reporting Standard applicable in the UK (FRS102). The Jane Hodge Foundation is a public benefit entity. 

## **Administrative information** 

## **Trustees** 

J Jonathan Hodge* (Family Trustee) Ian H Davies Karen L Hodge Helen C Molyneux (resigned 24 March 2022)* 

* Trustees who are or have been directors of The Carlyle Trust Limited and/or one or more of its subsidiaries during the year. 

## **Auditor** 

Ernst & Young LLP Bristol BS1 6BX 

## **Solicitors** 

Eversheds Sutherland 1 Callaghan Square Cardiff CF10 5BT 

## **Bankers** 

Hodge Bank One Central Square Cardiff CF10 1FS 

## **Investment Advisors** 

## **Deposits Cash Manager** 

Brewin Dolphin Limited Flagstone Group Ltd 5 Callaghan Square 1[st] Floor Cardiff Clareville House CF10 5BT 26-27 Oxenden Street London SW1Y 4EL 

## _**Registration number**_ 

The Jane Hodge Foundation is a registered charity, registration number 216053. 

## _**Registered office**_ 

One Central Square Cardiff CF10 1FS 

1 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Structure, governance and management** 

## _**Constitution**_ 

The Jane Hodge Foundation is an unincorporated trust, governed by a trust deed dated 15 October 1962.  It does not fundraise and seeks to pursue its objectives through careful stewardship of its resources. 

## _**Trustees**_ 

The Trustees who served during the year are set out above. The trust deed provides for a maximum of nine trustees.  The power of appointing or removing trustees is vested in the Family Trustee who takes into account the background and experience of trustees during the appointment process. 

The Trustees meet regularly, usually quarterly, to agree the broad strategy and areas of activity for the Foundation, including consideration of grant making, investment, risk management policies and performance.  The Trustees also undertake the day to day administration of grants and oversee the processing and handling of applications. 

The Trustees keep their skill requirements under review and subscribe to charity law and guidance publications. 

## _**Risk management**_ 

The Trustees are responsible for the Foundation’s system of internal control and for reviewing its effectiveness. This includes consideration of the major risks which the Foundation faces and the implementation of systems to mitigate those risks. The Trustees confirm they have examined during the 12-month period the major strategic, business and operational risks and have established systems to enable regular reports to be produced so that the necessary steps can be taken to lessen these risks.  The Trustees consider the variability of investment returns on the Foundation’s funds to constitute the most significant risk, which is monitored on a regular basis.  The Trustees currently have an investment strategy, which involves a managed investment portfolio in order to provide a stable level of income and long-term capital growth, with a medium risk profile. 

2 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## _**Objectives and activities**_ 

The objectives of the Foundation are to allocate income for general charitable purposes, with special regard to the following areas: 

- i. The encouragement of medical and surgical studies and research, and in particular the study of and research in connection with the causes, diagnosis, treatment and cure of cancer, poliomyelitis and tuberculosis and diseases affecting children; 

- ii. The general advancement of medical and surgical science; 

- iii. The advancement of education; 

- iv.The advancement of religion. 

Each application for a grant received in the year was considered against these objectives and applications were only considered from exempt or registered charities. 

The Trustees confirm that they have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing the Foundation’s aims and objectives and in planning future activities and setting the grant making policy for the year. 

## _**Policies**_ 

## **Reserves policy** 

The Trustees aim: 

- to distribute the net annual income to exempt charities and other charities registered with the Charity Commissioners mainly under the headings of medical care, medical research, education and religion; 

- to ensure that adequate reserves are retained in order to maintain the level of core stable revenue resources needed to support the ongoing programme of annual donations, taking into account the inherent volatility in the various income sources, and to provide funds for any future capital expenditure which may be required in support of projects such as hospices, education facilities, medical centres and daycare facilities. 

The Trustees’ current assessment of the target range of free reserves is £3m-£4m, based on resources expended during past years and that expected for future years. The current free reserves are significantly in excess of this target as they are used to generate future investment income . 

Free reserves, being unrestricted reserves less tangible fixed assets and charitable commitments, are £18,538,296 ( _2021: £_ 27,925,007 _)_ which includes £1,371,203 _(2021: £_ 4,557,577 _)_ relating to unrealised revaluations of investments.  The Trustees consider that this level of free reserves is currently appropriate to generate the annual total incoming resources to meet its strategic objectives. This view has been reinforced by the economic effect of the coronavirus pandemic, where many charities suffered severe financial stress. 

3 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Investment policy** 

With the assistance of its investment advisors, the Trustees have adopted a Statement of Investment Policy, which is reviewed annually. The objective of the policy is to achieve a balanced return from a diversified portfolio, adopting a medium risk approach. The Trustees have adopted an ethical policy, which seeks to avoid investment in companies that have any material activity connected with tobacco, alcohol, armaments, slave labour or discrimination.  They also review and monitor regularly the actions taken by their investment advisors in the application of socially responsible investment policies and principles. 

## **Grants policy** 

The Trustees have adopted a grants policy which sets out the general principles under which applications for grants are considered and, where appropriate, approved. The Trustees invite applications for grants from charitable institutions who submit a summary of their proposals. Grants are made only to registered and exempt charities. 

## **Financial review** 

As in previous years, this report is intended to provide some additional information to accompany the financial statements in order to explain the progress of current and future projects.  Details of incoming resources and resources expended are set out in the Statement of Financial Activities on page 13. 

The net unrestricted incoming resources before donations for the year to 30 September 2022 was £3,254,132 _(2021: £_ 5,839,853 _)_ , with grants payable for the year amounting to £5,974,588 _(2021: £_ 2,745,762). 

From the applications for grants received in the year, applications in respect of £5,974,588 _(2020:_ £2,745,762 _)_ met the criteria required and amounts were granted to the charities concerned.  The level of grants made each year can vary since there is a process of assessment and approval before grants can be made and grants may cover a period of more than one year.  Consequently, the grants reported in the Statement of Financial Activities can differ from the amount of grants paid in the year.  Actual donations paid in the year, including amounts committed in prior years, totalled £1,700,725 _(2021:_ £2,440,345 _)_ . 

## _**Achievements and performance**_ 

The objectives for the year were to continue to support medical care and research, to fund educational posts, mainly related to business and economics studies, and religious and other charities. 

The support of medical care and research has continued with £259,591 _(2021:_ 312,152) of new grants being made to various medical related charities.  The main focus has been on local hospices and research in the fields of cancer and mental health.  The Foundation has continued its sponsorship of education posts in business and economics related studies through its liaison with higher education establishments and has also supported other educational projects.  Grants made to educational charities totalled £5,082,700 _(2021:_ £766,835 _)_ .  Amounts granted for specific care and welfare projects within the aims and objectives of the Foundation totalled £614,209 _(2021: £_ 1,606,750 _)_ . The Foundation has also been able to support other charities of which three grants have been made totalling £1,600 _(2021: £2_ 2,400 _)_ .  Further details of the principal grants paid are set out below: 

4 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **The Prince’s Trust Cymru** 

The Trustees have supported the work of the Prince’s Trust with young people for many years.   In 2016 they agreed a three year commitment for the Trust’s “Achieve” programme in Wales.  This programme works with partner secondary schools to help young students, many with a range of developmental challenges, to engage with and succeed in education in a manner to support both academic performance and personal development.  Recognising the huge need for this type of early intervention provision across Wales, the Trustees then agreed to support a wider five-year programme running through to 31 March 2022, across the whole of Wales, that  enabled 7,912 young people to have access to Achieve over the period.  The total amount committed and paid over the five years amounted to just under £4m.  Notwithstanding the challenges presented by Covid-19,  2,369 young students were assisted through the Achieve programme in Wales in the year to the end of March 2022. The grant of £794,000 for the fifth and final  year of the programme was paid near the beginning of the financial year.  The Trustees are now in discussions with the management of the Prince’s Trust Cymru regarding possible future support, the need for which has grown even greater following the impacts of Covid and the cost of living crisis. 

## **Cardiff University – Hodge Centre for Neuropsychiatric Immunology** 

Major mental health disorders such as Alzheimer’s disease and schizophrenia are estimated to cost the UK economy over £37 billion per year. They continue to place a significant burden on patients and their relatives through reduced quality of life, increased physical illness and disability, lost employment, discrimination and isolation. In response to this, the Trustees supported a ground-breaking initiative at Cardiff University that brought together experts to explore the role the brain’s immune system plays in some of the most common brain disorders like Alzheimer’s, schizophrenia and epilepsy.  The five-year partnership, now in its final year, established the Hodge Centre for Neuropsychiatric Immunology and brought together leading researchers in both neuroscience and immunology. The Centre facilitated collaboration between Cardiff University’s Neuroscience and Mental Health Research Institute and Systems Immunity Research Institute under the leadership of their respective directors, Professor Jeremy Hall and Professor Paul Morgan. 

Following on from the success of that initiative, the Trustees have now awarded £5m over a further five year period to Cardiff University to establish the Hodge Centre for Translational Neuroscience.  The new centre will focus on the development of innovative new treatments for mental health conditions such as schizophrenia, bi-polar disorder and severe depression.  These conditions have a devastating effect on the lives of patients, often impacting family or work life, making it harder to keep a job or home. 

Cardiff University is already a world leader due to their pioneering research into genetics, neuroscience, and brain imaging.  The intention is for this support to help the researchers take these exciting scientific discoveries and translate them into real-world treatments for patients with schizophrenia and other major mood disorders. An important aspect of the Centre will be partnerships with industry, the NHS and charities so as to offer unique opportunities to make breakthroughs that would otherwise not happen. As part of the funding partnership, the University is creating a named Chair, the Hodge Professor of Psychiatry, and Professor Jeremy Hall will be the first person to hold this position. 

5 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Cardiff University - European Cancer Stem Cell Research Institute** 

In 2020 the Trustees agreed a three-year donation totalling £100,000, towards a PhD scholarship to support research into Blood Stem Cells and Leukaemia. This donation followed the previous commitment in May 2014 of £425,596 to establish the Hodge Foundation Cancer Research Programme within the European Cancer Stem Cell Research Institute (“ECSCRI”).  This support enabled the appointment of a Research Fellow and the provision of a PhD scholarship, leading to the start of a research group and contributing to a notable scientific breakthrough. 

Dr Fernando dos Anjos Afonso joined the ECSCRI team from Cancer Research UK and the Francis Crick Institute to begin his Hodge Foundation Fellowship in October 2015. Since then he has established a new lab and successfully led his group researching blood stem cells and Acute Myeloid Leukaemia, exploring the way normal human blood cells work, in order to better understand what is happening when they ‘go wrong’. 

Before coming to Cardiff, Dr Afonso was part of a team whose work led to the discovery of human blood precursor cells. These are essentially blood stem cells that have developed to a stage where they are committed to forming a particular kind of new blood cell. 

With the support of the Hodge Foundation, Dr Afonso and his research group have made an extremely significant scientific breakthrough in blood stem cell research.  Using a novel and simplified method, Dr Afonso has identified a group of rare primitive blood cells and has scientifically proved that these represent the purest blood stem cell population described to date in the world. This work has opened up a myriad of potentially new, important and exciting projects for exploration.  Dr Afonso believes that this discovery could be a breakthrough in the field of haematology as it will help better understand human blood formation and regeneration. This knowledge is crucial for transplantation and blood transfusion medicine, ageing of blood cells and the immune system, cardiovascular disease, and the origin of certain types of leukaemia. 

## **Cardiff Business School – Julian Hodge Institute of Applied Macroeconomics** 

The Foundation has had a long and happy association with Cardiff Business School (“CARBS”) and since 1999 this has been directed in particular through Professor Patrick Minford CBE and the Julian Hodge Institute of Applied Macroeconomics (“JHIAM”), which was set up in that year.  In recent years, the support has been split between that provided towards the research costs of JHIAM and that provided to help support economics PhD students with their living costs.  Since 2019, this has been simplified and the support for CARBS was rolled into a single grant of £140,000 towards the work of the School, including the work of JHIAM, commencing in the academic year 2019/20. 

Following discussions with CARBS about how best to support its public value mission “to bring humanity, sustainability, generosity and innovation to the business sector”,this has been packaged under a range of headings  incorporating a PhD scholarship programme, summer placements for undergraduate students, a social enterprise seedcorn fund to help students studying entrepreneurships to establish start-ups with a social and economic mission, and student prizes to celebrate and reward the achievement of academic excellence by undergraduates and postgraduates. The Trustees agreed a three-year package of support totalling £450,000, with the first payment made in June 2021.  The second of the three payments was made in July 2022. 

6 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Arts & Business Cymru** 

The Trustees have supported Arts & Business Cymru’s “CultureStep” programme for many years.  This provides matching equity to encourage new sponsorship and develop established business engagement with the arts.  CultureStep invests in projects which engage in art for the benefit of children, the elderly, the sick and the environment.  This year, the Trustees agreed a further package of support for two years totalling £140,000. 

## **City Hospice** 

This charity delivers palliative care to adults with life-limiting illnesses across the whole of Cardiff, either within their own homes or at their purpose-built day centre in Whitchurch, Cardiff.  The Trustees have supported City Hospice since its inception in 1984.  This year, the Trustees once again committed £100,000 of match funding towards the annual “Light up a Life” campaign. 

## **The Duke of Edinburgh’s Award Scheme** 

The Trustees have been long-time supporters of the Award Scheme in Wales.  In 2020, the Trustees agreed a grant of £50,000 towards programme development in four operational areas in Wales.  Building on this, the Trustees then agreed a further grant of £194,335 to support the Scheme’s ‘Youth Without Limits’ project for the first year in a three-year programme.  The aim of this is to ensure that young people from disadvantaged and marginalised backgrounds in Wales can access the Awards Scheme in a supportive environment within their school or local community. The project aims to achieve this in two ways: 

Firstly, by enabling community and voluntary youth sector groups to establish the Awards Scheme, helping them to become sustainable delivery partners, through a programme of targeted operational and financial support. 

Secondly, by offering a package of support to 54 schools in which over 25% of students are eligible for free school meals. This support will enable existing centres to sustain and grow their Award Scheme offering, and help under-performing centres to re-start and develop their delivery. 

A priority in all aspects of the project is ensuring that young people who are marginalised or face specific barriers to participation are fully included. The committed support of £194,335 was paid during the year. 

## **Teenage Cancer Trust** 

A one-off donation of £48,991 was agreed by the Trustees to support the costs of a Teenage & Young Adult Lead Nurse at University Hospital of Wales, Cardiff, for a further year. The Lead Nurse supports around 80 young people a year, ensuring that they receive the best possible clinical care and support, and that patients are treated as young people first and cancer patients second.  Young people are encouraged to engage with their new online community ( _Connect_ ), so they can talk to their peers in a safe and secure way; and access streamlined support from frontline staff, through a secure online connection. The Lead nurse also supports the young people’s parents/carers, partners and friends through the practical and emotional challenges they are experiencing when their loved ones are diagnosed, are going through gruelling treatment, or receiving difficult news. 

7 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Aloud** 

The Trustees have supported for several years the activities of the Aloud charity, which works with young people through the medium of song. The mission of Aloud is to engage each new generation of young people across Wales with the power of choral singing and through this activity to promote self-belief and self-confidence, to encourage aspiration, to build skills and to develop a sense of community. They believe in encouraging young people to find their own way and to make their own mark, using choral singing as a catalyst to effect positive change in their lives. This year, the Trustees agreed a grant of £35,000 to support the artistic and administrative activity of 8 Only Boys Aloud choirs in South Wales for 2022, in some of the most socio-economically deprived areas of the country. 

## _**Organisation**_ 

The administration of the Foundation continues to be based at the offices of Hodge Bank, One Central Square in Cardiff’s city centre. The Foundation still benefits significantly from the skills and expertise of the Bank’s senior management, for which the Trustees are very grateful and this has allowed the Foundation to maintain its own administration costs at their very low level for another year. 

A high proportion of the Foundation’s income now comes from dividends paid by The Carlyle Trust Limited, with £2,607,873 of dividend income received during the year. The Trustees would like to thank the hard work and commitment of all the staff at Hodge Bank. 

## _**Future**_ 

The Trustees will continue to encourage applications for grants from charities whose objectives are in accordance with the aims and objectives of the Foundation.  Particular emphasis will continue to be given to supporting medical research, especially in the fields of cancer and mental health, and to funding educational initiatives, projects relating to business and economics and religious and other charities. There will also be a focus on improving outcomes for those living in less affluent areas of Wales. 

## _**Disclosure of information to auditor**_ 

The Trustees who held office at the date of approval of this Trustees’ Report confirm that, so far as they are each aware, there is no relevant audit information of which the Charity’s auditor is unaware; and each Trustee has taken all the steps that he or she ought to have taken as a Trustee to make himself or herself aware of any relevant audit information and to establish that the Trustee’s auditor is aware of that information. 

By order of the Board of Trustees 

**J Jonathan Hodge** _Trustee_ 26 May 2023 

8 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Statement of Trustees’ Responsibilities in Respect of the Trustees’ Annual Report and the Financial Statements** 

Under charity law, the Trustees are responsible for preparing the Trustees' Annual Report and  Financial Statements for each financial year which show a true and fair view of the state of affairs of the Charity and of the excess of income over expenditure, being net incoming resources, for that year. 

In preparing these financial statements, generally accepted accounting practice entails that the Trustees: 

- select suitable accounting policies and then apply them consistently; 

- make judgements and estimates that are reasonable and prudent; 

- state whether applicable UK Accounting Standards and the Statement of Recommended Practice have been followed, subject to any material departures disclosed and explained in the financial statements; 

- state whether the financial statements comply with the trust deed, subject to any material departures disclosed and explained in the financial statements; 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue its activities. 

The Trustees are required to act in accordance with the trust deed of the Charity and within the framework of trust law. They are responsible for keeping proper accounting records, sufficient to disclose at any time, with reasonable accuracy, the financial position of the Charity at that time, and to enable the Trustees to ensure that, where any statements of accounts are prepared by them under section 132(1) of the Charities Act 2011, those statements of accounts comply with the requirements of regulations under that provision. They have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the Charity and to prevent and detect fraud and other irregularities. 

9 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **INDEPENDENT AUDITOR’S REPORT TO THE TRUSTEES OF THE JANE HODGE FOUNDATION** 

## **Opinion** 

We have audited the financial statements of The Jane Hodge Foundation for the year ended 30 September 2022 which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and the related notes 1 to 16, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) including FRS 102 “The Financial Reporting standard applicable in the UK and Republic of Ireland”. 

In our opinion the financial statements: 

- give a true and fair view of the state of the Charity’s affairs as at 30 September 2022 and of its incoming resources and application of resources, for the year then ended; 

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and 

- have been prepared in accordance with the requirements of the Charities Act 2011. 

## **Basis for opinion** 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report below. We are independent of the Charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

## **Conclusions relating to going concern** 

In auditing the financial statements, we have concluded that the Trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate. 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Charity’s ability to continue as a going concern for a period to 31 May 2024. 

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.  However, because not all future events or conditions can be predicted, this statement is not a guarantee as to the Charity’s ability to continue as a going concern. 

## **Other information** 

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon.  The Trustees are responsible for the other information contained in the annual report. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of the other information, we are required to report that fact. 

We have nothing to report in this regard. 

10 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Matters on which we are required to report by exception** 

We have nothing to report in respect of the following matters where the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion: 

- the information given in the Trustees’ Annual Report is inconsistent in any material respect with the financial statements; or 

- sufficient accounting records have not been kept; or 

- the financial statements are not in agreement with the accounting records and returns; or 

- we have not received all the information and explanations we require for our audit. 

## **Responsibilities of trustees** 

As explained more fully in the Statement of Trustees’ Responsibilities set out on page 9, the Trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

In preparing the financial statements, the Trustees are responsible for assessing the Charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the Charity or to cease operations, or have no realistic alternative but to do so. 

## **Auditor’s responsibilities for the audit of the financial statements** 

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder. 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

11 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud** 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect irregularities, including fraud. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and management. 

- We obtained an understanding of the legal and regulatory frameworks that are applicable to the Charity and determined that the most significant are those that relate to the reporting framework (the Charity’s trust deed, the Charities Act 2011 and Accounting and Reporting by Charities (second edition October 2019): Statement of Recommended Practice applicable to charities in accordance with the Financial Reporting Standard applicable in the UK (FRS102), and supervisory requirements  under the Charities Commission. 

- We understood how the Charity is complying with those frameworks by making inquiries of management and those responsible for legal and compliance matters. We also reviewed minutes of Trustee meetings and gained an understanding of the Charity’s governance framework. 

- We assessed the susceptibility of the Charity’s financial statements to material misstatement, including how fraud might occur by considering the controls established to address the risks identified to prevent or detect fraud. We made inquiries of management and obtained an understanding of management’s incentives and opportunities for fraudulent manipulation of the financial statements and considered the risk of override of controls specifically on grants expenditure and also considered risk of misappropriation of assets. 

- Based on this understanding we designed our audit procedures to identify noncompliance with such laws and regulations. Our procedures involved obtaining third party confirmations for bank accounts and investments, inspecting responses from donation recipients to ensure that income statement donations were appropriately paid during the year, agreeing future commitments to evidence which sets an expectation of payment, and reviewing Trustee minutes to identify potential undisclosed commitments. 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report. 

## **Use of our report** 

This report is made solely to the Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008.  Our audit work has been undertaken so that we might state to the Charity's Trustees those matters we are required to state to them in an auditors' report and for no other purpose.  To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Charity and the Charity’s Trustees as a body, for our audit work, for this report, or for the opinions we have formed. 


## Ernst & Young LLP (Statutory Auditor) 

Bristol 26 May 2023 

Ernst & Young LLP is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006 

12 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Statement of Financial Activities** _**for the year ended 30 September 2022**_ 

||_Note_|Unrestricted|Expendable|**Total**|Total|
|---|---|---|---|---|---|
|||funds|Endowment|||
||||funds|||
|||2022|2022|**2022**|2021|
|||£|£|**£**|£|
|**Incoming resources**||||||
|_Incoming resources from_||||||
|_generated funds_||||||
|Investment income:||||||
|Listed investment income||775,831|-|**775,831**|801,029|
|Unlisted investment income||2,607,873|-<br>|**2,607,873**|5,215,746|
|**Total incoming resources**||**3,383,704**|**-**<br>|**3,383,704**|6,016,775|
|**Resources expended**||||||
|Charitable activities|_6_|5,974,588|-|**5,974,588**|2,745,762|
|Cost of generating funds|_7_|121,832|-|**121,832**|171,813|
|Governance costs|_8_|7,740|-<br>|**7,740**|5,109|
|**Total resources expended**||**6,104,160**|**-**<br>|**6,104,160**|2,922,684|
|**Net (outgoing)/incoming**||**(2,720,456)**|**-**|**(2,720,456)**|3,094,091|
|**resources**||||||
|**Other recognised gains and**||||||
|**losses**||||||
|(Loss) / gain on investments||**(2,435,278)**|**(1,592,636)**<br>|**(4,027,914)**|7,994,062|
|**Net movement in funds**||**(5,155,734)**|**(1,592,636)**|**(6,748,370)**|11,088,153|
|**_Reconciliation of funds_**||||||
|**Total funds brought forward**||**29,527,186**|**22,534,859**<br>|**52,062,045**|40,973,892|
|**Total funds carried forward**||**24,371,452**|**20,942,223**|**45,313,675**|52,062,045|



The financial activities set out above are all in respect of the continuing activities of the Charity. 

The notes on pages 16 to 24 form part of these financial statements. 

13 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Balance Sheet** 

## _**at 30 September 2022**_ 

|_Note_<br>**Non-current assets**<br>Investments<br>_10_<br>Cash held by investment manager<br>for investment purposes<br>**Current assets**<br>Debtors<br>_11_<br>Cash at bank and in hand<br>Cash held by cash investment<br>manager<br>**Creditors:**amounts falling due<br>within one year<br>_12_<br>**Net current assets**<br>**Creditors:**amounts falling due<br>after more than one year<br>_13_<br>**Net assets**<br>**_The Funds of the Charity_**<br>**Expendable endowment funds**<br>_14_<br>**Unrestricted income funds**<br>_15_<br>**Funds**|Unrestricted<br>funds<br>Expendable<br>Endowment<br>funds<br>**2022**<br>**Total**<br>£<br>£<br>**£**<br>20,804,708<br>20,942,223<br>**41,746,931**<br>2,349,549<br>-<br>**2,349,549**<br> <br>23,154,257<br>20,942,223<br>**44,096,480**<br> <br>143,628<br>-<br>**143,628**<br>1,954,943<br>-<br>**1,954,943**<br>4,998,490<br>-<br>**4,998,490**<br> <br>7,097,061<br>-<br>**7,097,061**<br>(1,788,066)<br>-<br>**(1,788,066)**<br> <br>**5,308,995**<br>**-**<br>**5,308,995**<br> <br>(4,091,800)<br>**-**<br>**(4,091,800)**<br> <br>**24,371,452**<br>**20,942,223**<br>**45,313,675**<br> <br>-<br>20,942,223<br>**20,942,223**<br>24,371,452<br>-<br>**24,371,452**<br> <br>**24,371,452**<br>**20,942,223**<br>**45,313,675**|2021<br>Total<br>£<br>46,961,107<br>1,280,895<br>48,242,002<br>145,099<br>5,311,551<br>-<br>5,456,650<br>(1,407,213)<br>4,049,437<br>(229,395)<br>52,062,044<br>22,534,859<br>29,527,185<br>52,062,044|
|---|---|---|



The notes on pages 16 to 24 form part of these financial statements. 

These financial statements were approved by the Trustees on 26 May 2023 and were signed on their behalf by: 

**J J Hodge** _Trustee_ 

Registered number: 216053 

14 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


|**Statement of Cash Flows**|||
|---|---|---|
|**_for the year ended 30 September 2022_**|||
||**2022**|2021|
||**£**|£|
|**Cash flows from operating activities:**|||
|Net cash used in operating activities (Table 1)|**(1,859,431)**|(2,672,774)|
|**Cash flows from investing activities:**|||
|Dividends, interest and rents from investments|**3,383,704**|6,016,775|
|Proceeds from sale of investments|**7,304,653**|18,786,375|
|Purchase of investments|**(6,118,390)**|(18,292,427)|
|**Net cash provided by investing activities**|**4,569,967**|6,510,723|
|**Change in cash and cash equivalents in the year**|**2,710,536**|3,837,949|
|**Cash and cash equivalents at the beginning of the year, being cash**|**6,592,446**|2,754,497|
|**at bank, in hand and held by third parties**|||
|**Cash and cash equivalents at the end of the year, being cash at bank,**|**9,302,982**|6,592,446|
|**in hand and held by third parties**|||
|**Table 1: Reconciliation of net income to net cash flow from operating**|||
|**activities**|||
||**2022**|2021|
||**£**|£|
|**Net (outgoing)/ incoming resources (as per Statement of Financial**|||
|**Activities)**|**(2,720,456)**|3,094,091|
|Adjustments for:|||
|Amortisation charges|**-**|7,882|
|Dividends, interest and rents from investments|**(3,383,704)**|(6,016,775)|
|Decrease / (Increase) in debtors|**1,471**|(74,590)|
|Increase in creditors|**4,243,258**|316,618|
|**Net cash used in operating activities**|**(1,859,431)**|(2,672,774)|
|**Analysis of cash**|**2022**|2021|
||**£**|£|
|Cash held by investment manager for investment purposes|**2,349,549**|1,280,895|
|Cash at bank and in hand|**1,954,943**|5,311,551|
|Cash held by cash investment manager|**4,998,490**|-|
|**Total cash at bank, in hand and held by third parties**|**9,302,982**|6,592,446|



15 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **Notes to the financial statements** 

## **1 Accounting policies** 

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the Foundation’s financial statements. 

## _**Basis of preparation**_ 

The financial statements have been prepared in accordance with the Foundation’s trust deed, the Charities Act 2011 and Accounting and Reporting by Charities (second edition October 2019): Statement of Recommended Practice applicable to charities in accordance with the Financial Reporting Standard applicable in the UK (FRS102). 

## _**Going concern**_ 

The financial statements are prepared on a going concern basis. The Foundation has net current assets of £5,308,995 _._ The Trustees have considered the level of assets held together with the future grant expenditure plan, and the plausible effects of the high inflationary and higher interest rate environment on its financial situation and future cashflows. The Trustees are satisfied that the Charity will be able to meet any liabilities as and when they fall due for a period to 31 May 2024. 

## _**Incoming resources**_ 

All incoming resources are recognised once the Foundation has entitlement to the resources, it is certain that the resources will be received, and the monetary value of incoming resources can be measured with sufficient reliability. 

## _**Investments and investment income**_ 

Listed investments are shown at their market value, with all gains or losses taken to the Statement of Financial Activities.  Unlisted investments are initially recorded at cost and revalued annually to reflect their market value unless a reliable estimate of their market value is not available. 

Any gain or loss in relation to investments held in the expendable endowment fund is retained in the expendable endowment fund, with the income generated by the fund freely available to fund the activities of the Charity and consequently is allocated to the unrestricted fund. 

Dividend income is accounted for when received. 

16 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **1 Accounting policies** _(continued)_ 

## _**Resources expended**_ 

All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of the resources. 

Overhead and support costs have been allocated between charitable activity and governance, and apportioned between charitable activities based on the number of individual grant awards made.  Governance costs relate to those costs involving the public accountability of the Charity and its compliance with regulation and good practice. These costs include costs relating to the statutory audit and legal fees. 

## _**Gifted assets**_ 

Non-current assets gifted to the Foundation are included in the financial statements at valuation when gifted. 

## _**Expendable endowment funds**_ 

Expendable endowment funds comprise funds relating to assets gifted to the Foundation together with any gains or losses arising from the disposal of such assets and subject to the conditions of the donor.  The income generated by the fund is freely available to fund the activities of the Charity and consequently is allocated to the unrestricted fund. 

## _**Unrestricted general funds**_ 

These are funds, which can be used in accordance with the charitable objects at the discretion of the Trustees. 

## _**Designated funds**_ 

These are funds set aside by the Trustees out of unrestricted general funds for specific future purposes or projects. 

## _**Grants payable**_ 

Grants payable are made to third parties in the furtherance of the charitable objectives of the Trust.  Grants payable are charged in the year when the offer is conveyed to the recipient except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure. 

## _**Taxation**_ 

The Jane Hodge Foundation is considered to pass the tests set out in Paragraph 1 Schedule 6 Finance Act 2011 and therefore it meets the definition of a charitable trust for UK income tax purposes. Accordingly, the Charity is exempt from taxation in respect of income or capital gains received within categories covered by Part 10 Income Tax Act 2007 or Section 256 of the Taxation and Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes. 

17 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


|**2**<br>**Net incoming resources for year**<br>**_Net incoming resources for the year are stated after_**<br>**_charging:_**<br>Auditor’s remuneration – audit of financial statements|**2022**<br>**£**<br>**5,610**<br>|2021<br>£<br>5,109|
|---|---|---|



## **3 Trustees’ remuneration and expenses** 

The Trustees did not receive any remuneration from the Foundation during the year _(2021: £nil)._ No amounts were paid to Trustees during the year in respect of professional services independent of their role as Trustees, _(2021: £nil)._ No expenses were received by Trustees in either year. 

Several of the Trustees, as indicated in the Trustees’ Report, are non-executive directors of The Carlyle Trust Limited and one or more of its subsidiary companies. Their remuneration in their capacity as directors is included within the remuneration of directors disclosed in the financial statements of those companies. 

## **4 Staff numbers and costs** 

The average number of persons employed by the Foundation (excluding those trustees who received no remuneration) during the year was One (2021: One). The aggregate payroll costs of those persons were as follows: 

|Wages and salaries<br>Social security costs<br>Other pensions costs|**2022**<br>**£**<br>**13,733**<br>**1,097**<br>**1,544**<br>**16,374**|2021<br>£<br>20,278<br>1,589<br>3,599|
|---|---|---|
|||25,466|



18 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **5 Allocation of support costs** 

The breakdown of support costs and their allocation to charitable activities is as follows: 

|Administrative costs recharged<br>Office costs|**2022**<br>**£**<br>**16,374**<br>**114**<br>**16,488**|2021<br>£<br>25,466<br>12,159<br>37,625|
|---|---|---|



The total support costs allocated to charitable activities are then apportioned pro-rata to the number of grants awarded. 

## **6 Charitable activities** 

The Foundation undertakes its charitable activities through grant making and awards grants to a number of institutions in furtherance of its charitable activities. 

||**Number**|**Grant funded**|**Support**|**Total**|Number|Total|
|---|---|---|---|---|---|---|
||**of**|**activity**|**costs**|**2022**|of grants|2021|
||**grants**||||||
|||**£**|**£**|**£**||£|
|Care & Welfare|38|614,209|8,033|**622,242**|38|1,628,413|
|Education|20|5,082,700|4,228|**5,086,928**|9|771,966|
|Medical Research|17|259,591|3,594|**263,185**|13|319,563|
|Other|3<br>|1,600|633|**2,233**<br>|6<br>|25,820|
||78|5,958,100|16,488|**5,974,588**|66|2,745,762|
|||||**-**|||



**7 Cost of generating funds** 

||**2022**|2021|
|---|---|---|
||**£**|£|
|Investment management cost|**121,832**|171,813|



19 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


|**8**<br>**Governance costs**<br>Auditor’s remuneration<br>Irrecoverable VAT on above<br>**9**<br>**Comparatives for the**<br>**statement of financial activities**<br>Unrestricted<br>funds<br>2021<br>£<br>**Incoming resources**<br>_Incoming resources from generated funds_<br>Investment income:<br>Listed investment income<br>801,029<br>Unlisted investment income<br>5,215,746<br> <br>**Total incoming resources**<br>6,016,775<br> <br>**Resources expended**<br>Charitable activities<br>2,745,762<br>Cost of generating funds<br>171,813<br>Governance costs<br>5,109<br> <br>**Total resources expended**<br>2,922,684<br> <br>**Net incoming resources**<br>3,094,091<br> <br>**Other recognised gains and losses**<br>Gain on investments<br>4,816,497<br> <br>**Net movement in funds**<br>7,910,588<br>**_Reconciliation of funds_**<br>Total funds brought forward<br>21,616,598<br> <br>**Total funds carried forward**<br>29,527,186<br>|**2022**<br>**£**<br>**5,610**<br>**2,130**<br>**7,740**<br>Expendable<br>Endowment<br>funds<br>2021<br>£<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>3,177,565<br>3,177,565<br>19,357,294<br>22,534,859||**2022**<br>**£**<br>**5,610**<br>**2,130**|<br> <br> <br> <br>|2021<br>£<br>5,109<br>-<br> 5,109<br>Total<br>2021<br>£<br>801,029<br>5,215,746<br>6,016,775<br>2,745,762<br>171,813<br>5,109<br>2,922,684<br>3,094,091<br>7,994,062<br>11,088,153<br>40,973,892<br>52,062,045|2021<br>£<br>5,109<br>-|
|---|---|---|---|---|---|---|
||||<br>**7,740**||||
||||||||
||||||||
||||||||
||||||||
||||||||
||||||||
||||||||



20 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **10 Non current asset investments** 

|||**Listed**|**Unlisted**|**Total**|
|---|---|---|---|---|
|||**investments**|**Investments**||
|||**£**|**£**|**£**|
|**_Cost_**|||||
|At beginning of year||33,858,141|5,555,422|39,413,563|
|Purchases||6,118,390|-|6,118,390|
|Disposals||(6,058,701)<br>|-<br>|(6,058,701)|
|**At end of year**||**33,917,830**<br>|**5,555,422**<br>|**39,473,252**|
|**_Revaluation reserve_**|||||
|At beginning of year||7,547,544|-|7,547,544|
|Movement in year -|realised on disposal|(1,245,951)|-|(1,245,951)|
||- revaluation in year|(4,027,914)<br>|-<br>|(4,027,914)|
|**At end of year**||**2,273,679**<br>|**-**<br>|**2,273,679**|
|**_Market value_**|||||
|**At 30 September 2022**||**36,191,509**<br>|**5,555,422**|**41,746,931**|
|At 30 September 2021||41,405,685<br>|5,555,422|46,961,107|



Listed investments held by the Foundation are shown at market value at the Balance Sheet date. 

The unlisted investment in The Carlyle Trust Limited was acquired as a series of gifts and purchases. The latest was a transfer from The Sir Julian Hodge Charitable Trust, now wound up. The carrying value is based on the aggregate of the valuations at the date of each gift, the carrying value of the shares transferred, and the consideration for those shares purchased. 

21 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **10 Non current asset investments** _(continued)_ 

Investments in individual entities at 30 September 2022, which are 5% or more of the portfolio by value, are: 

## _Unlisted investments_ 

The Carlyle Trust Limited - £5,555,422 

## _**Unlisted investment**_ 

|**_nlisted investment_**||||
|---|---|---|---|
||**Country of**|**Principal**|**Class and**|
||**registration**|**activity**|**percentage**|
||**or incorporation**||**of shares**|
||||**held**|
|The Carlyle Trust Limited|UK|Finance|79%|
||||ordinary|



The Carlyle Trust Limited is not considered to be a subsidiary undertaking as the Foundation only owns 39.5% of the voting shares. 

The following summarises the consolidated Balance Sheet of The Carlyle Trust Limited at 30 September: 

|**2022**<br>**£**<br>Share capital<br>**1,100,000**<br>Reserves<br>**329,800,000**<br>Total equity<br>**330,900,000**<br>Profit/(loss) for the year<br>**7,300,000**|2021<br>£<br>1,100,000<br>319,000,000<br>320,100,000<br>(4,200,000)|
|---|---|



Income from the investment in The Carlyle Trust Limited amounted to £2,607,873 being dividend income received _(2021:_ £5,215,746 _)_ . 

## _**Investment disposals**_ 

The total realised revaluation gain for all investments sold during the year is shown on the table below: 

||**2022**|2021|
|---|---|---|
||**£**|£|
|Sale proceeds on disposal|**7,304,653**|18,786,375|
|Cost of investments sold|**(6,058,701)**|(13,378,082)|
||**1,245,952**|5,408,293|



22 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


|**11**<br>**Debtors**<br>**2022**<br>**£**<br>Prepayments and accrued income<br>**143,628**<br> <br>**12**<br>**Creditors: amounts falling due within one year**<br>**2022**<br>**£**<br>Grants payable<br>**1,741,356**<br> <br>Other creditors<br>**46,710**<br>**_______**<br>**1,788,066**<br> <br>**13**<br>**Creditors: amounts falling due after more than one year**<br>**2022**<br>**£**<br>Grants payable<br>**4,091,800**<br>**14**<br>**Expendable endowment funds**|2021<br>£<br>145,099<br>2021<br>£<br>1,372,783<br>34,430<br>_______<br>1,407,213<br>2021<br>£<br>229,395|
|---|---|



The expendable endowment funds, established in accordance with the wishes of the donor, include: 

|**Fixed assets**<br>**and**<br>**investments**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and**<br>**property**<br>**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of year<br>15,227,510<br>4,317,290<br>2,990,059<br>**22,534,859**<br>Unrealised gains in the year<br>**-**<br>-<br>(1,592,636)<br>**(1,592,636)**<br>Realised gains in the year<br>**-**<br>494,855<br>(494,855)<br>**-**<br> <br>**At end of year**<br>**15,227,510**<br>**4,812,145**<br>**902,568**<br>**20,942,223**|**Fixed assets**<br>**and**<br>**investments**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and**<br>**property**<br>**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of year<br>15,227,510<br>4,317,290<br>2,990,059<br>**22,534,859**<br>Unrealised gains in the year<br>**-**<br>-<br>(1,592,636)<br>**(1,592,636)**<br>Realised gains in the year<br>**-**<br>494,855<br>(494,855)<br>**-**<br> <br>**At end of year**<br>**15,227,510**<br>**4,812,145**<br>**902,568**<br>**20,942,223**|**Fixed assets**<br>**and**<br>**investments**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and**<br>**property**<br>**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of year<br>15,227,510<br>4,317,290<br>2,990,059<br>**22,534,859**<br>Unrealised gains in the year<br>**-**<br>-<br>(1,592,636)<br>**(1,592,636)**<br>Realised gains in the year<br>**-**<br>494,855<br>(494,855)<br>**-**<br> <br>**At end of year**<br>**15,227,510**<br>**4,812,145**<br>**902,568**<br>**20,942,223**|**Fixed assets**<br>**and**<br>**investments**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and**<br>**property**<br>**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of year<br>15,227,510<br>4,317,290<br>2,990,059<br>**22,534,859**<br>Unrealised gains in the year<br>**-**<br>-<br>(1,592,636)<br>**(1,592,636)**<br>Realised gains in the year<br>**-**<br>494,855<br>(494,855)<br>**-**<br> <br>**At end of year**<br>**15,227,510**<br>**4,812,145**<br>**902,568**<br>**20,942,223**|**Fixed assets**<br>**and**<br>**investments**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and**<br>**property**<br>**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>**£**<br>**£**<br>At beginning of year<br>15,227,510<br>4,317,290<br>2,990,059<br>**22,534,859**<br>Unrealised gains in the year<br>**-**<br>-<br>(1,592,636)<br>**(1,592,636)**<br>Realised gains in the year<br>**-**<br>494,855<br>(494,855)<br>**-**<br> <br>**At end of year**<br>**15,227,510**<br>**4,812,145**<br>**902,568**<br>**20,942,223**|
|---|---|---|---|---|
||<br>**-**|<br> <br> <br>-<br>(1,592,636)<br>**(1,592,636)**|||
||**-**|494,855|(494,855)|**-**|
|||<br>**4,812,145**|**902,568**<br>**20,942,223**||



23 



DocuSign Envelope ID: 044E0011-AA39-4F7F-AC22-481605938A20 

Registered number 216053 Financial statements 30 September 2022 


## **15 Unrestricted income funds** 

These comprise those funds, which the Trustees are free to use in accordance with the charitable objectives. 

|**Net incoming**<br>**resources**<br>**excluding**<br>**gains/(losses)**<br>**on**<br>**investments**<br>**and property**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and property**<br> <br>**£**<br>**£**<br>At beginning of year<br>14,950,125<br>10,019,483<br>Net incoming resources<br>for year<br>(2,720,456)<br>-<br>Unrealised gains in year<br>-<br>-<br>Realised gains in year<br>-<br>751,097<br>**At end of year**<br>**12,229,669**<br>**10,770,580**<br>Unrestricted funds comprise:<br>General funds|**Net incoming**<br>**resources**<br>**excluding**<br>**gains/(losses)**<br>**on**<br>**investments**<br>**and property**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and property**<br> <br>**£**<br>**£**<br>At beginning of year<br>14,950,125<br>10,019,483<br>Net incoming resources<br>for year<br>(2,720,456)<br>-<br>Unrealised gains in year<br>-<br>-<br>Realised gains in year<br>-<br>751,097<br>**At end of year**<br>**12,229,669**<br>**10,770,580**<br>Unrestricted funds comprise:<br>General funds|**Net incoming**<br>**resources**<br>**excluding**<br>**gains/(losses)**<br>**on**<br>**investments**<br>**and property**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and property**<br> <br>**£**<br>**£**<br>At beginning of year<br>14,950,125<br>10,019,483<br>Net incoming resources<br>for year<br>(2,720,456)<br>-<br>Unrealised gains in year<br>-<br>-<br>Realised gains in year<br>-<br>751,097<br>**At end of year**<br>**12,229,669**<br>**10,770,580**<br>Unrestricted funds comprise:<br>General funds|**Net incoming**<br>**resources**<br>**excluding**<br>**gains/(losses)**<br>**on**<br>**investments**<br>**and property**<br>**Profit on**<br>**disposal of**<br>**investments**<br>**and property**<br> <br>**£**<br>**£**<br>At beginning of year<br>14,950,125<br>10,019,483<br>Net incoming resources<br>for year<br>(2,720,456)<br>-<br>Unrealised gains in year<br>-<br>-<br>Realised gains in year<br>-<br>751,097<br>**At end of year**<br>**12,229,669**<br>**10,770,580**<br>Unrestricted funds comprise:<br>General funds|**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>4,557,577<br>**29,527,185**|**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>4,557,577<br>**29,527,185**|**Unrealised**<br>**investment**<br>**revaluation**<br>**reserve**<br>**Total**<br>**£**<br>**£**<br>4,557,577<br>**29,527,185**|
|---|---|---|---|---|---|---|
||(2,720,456)|-||-<br>**(2,720,456)**|||
||-|-||(2,435,277)<br>**(2,435,277)**|||
||-|751,097|||<br> <br>(751,097)|<br>**-**|
||||||||
||||||||
||||||||
||||||||
||**12,229,669**|**10,770,580**|||**1,371,203**|**24,371,452**|
|||||**2022**<br>**£**<br>**24,371,452**||2021<br>£<br>29,527,185|



## **16 Related party transactions** 

Related party transactions in the year were as follows: 

Dividend income received in the year from The Carlyle Trust Limited amounted to £2,607,873 _(2021:_ £5,215,746 _)._ 

Bank deposits held with Julian Hodge Bank, a subsidiary of The Carlyle Trust Limited, at 30 September 2022 amounted to £1,954,943 (2021: £5,311,551). 

Amounts owed to Julian Hodge Bank, a subsidiary of The Carlyle Trust Limited, at 30 September 2022 amounted to £10,588 (2021: £31,397). 

There were no other related party transactions. 

24